On the one hand, it is frequently found in the literature that poorly differentiated tumor cells (e.g., triple-negative breast cancer; colorectal cancer; endometrial cancer) are characterized by reduced expression of E-cadherin [74]. This evidence concerns the gene CDH1 and triple-negative breast carcinoma.